ArticleThe oncologist2025

Treatment with programmed-death-1 inhibitors for non-melanoma skin cancer among immunocompromised patients with subgroup analysis of solid organ transplant patients.

Eyal Yosefof et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.